Home
Biodonostia HRI

Biodonostia HRI Market Share Analysis for April 2026

Instituto de investigación sanitaria de excelencia, referencia a nivel nacional e internacionalen · Donostia / San Sebastián

Health > Health - Other

Domainbiodonostia.org

Year Founded--

Employees51 - 200

Annual Revenue--

Biodonostia HRI

Biodonostia HRI (including company regionals)

biodonostia.org

See more website traffic and engagement information

Total visits to Biodonostia HRI's top domains

Understand Biodonostia HRI market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biodonostia.org9.9K

See more with Sales Intelligence

Avg. visit duration in Biodonostia HRI's top domains

Analyze Biodonostia HRI engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biodonostia.org00:02:13

See more with Sales Intelligence

Avg. pageviews on Biodonostia HRI's top domains

See how Biodonostia HRI keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biodonostia.org1.87

See more with Sales Intelligence

Biodonostia HRI top competitors by domain

Top similar sites in April 2026, ranked by their affinity

stamboulian.com.arCompany NameStamboulianEmployees201 - 500HQArgentina, TandilAnnual revenue--Total visits53.2KHealth > Health - Other

Top technologies used by Biodonostia HRI

These are the website technologies, by industry, used by Biodonostia HRI top domains

Widget (8)

Twemoji

Social (6)

Instagram

Advertising (3)

Google Adsense

Audio Video Media (2)

YouTube

More Technologies

10

See all

News & Signals from Biodonostia HRI

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiodonostia partners with EHU.A multidisciplinary team from the Biogipuzkoa Health Research Institute, the Department of Health and Osakidetza, in collaboration with the University of the Basque Country (EHU), has developed and patented a new chemotherapy formula that has shown remarkable effectiveness against an aggressive type of liver cancer with a very poor prognosis, known as cholangiocarcinoma.